Evidence map›Paper›PMID 33691117›Full record

ArticleCell reports2021

Integrin β1 coordinates survival and morphogenesis of the embryonic lineage upon implantation and pluripotency transition.

Matteo Amitaba Molè, Antonia Weberling, Reinhard Fässler, Alison Campbell, Simon Fishel, Magdalena Zernicka-Goetz

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Exploring the role of ITGB6: fibrosis, cancer, and other diseases.Apoptosis : an international journal on programmed cell death · 2024
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Matteo Amitaba MolèMammalian Embryo and Stem Cell Group, Department of Physiology, Development, and Neuroscience, University of Cambridge, Downing Street, Cambridge CB2 3EG, UK.
Antonia WeberlingMammalian Embryo and Stem Cell Group, Department of Physiology, Development, and Neuroscience, University of Cambridge, Downing Street, Cambridge CB2 3EG, UK.
Reinhard FässlerDepartment of Molecular Medicine, Max Planck Institute of Biochemistry, Am Klopferspitz 18, 82152 Martinsried, Germany.
Alison CampbellCARE Fertility Group, John Webster House, 6 Lawrence Drive, Nottingham Business Park, Nottingham NG8 6PZ, UK.
Simon FishelCARE Fertility Group, John Webster House, 6 Lawrence Drive, Nottingham Business Park, Nottingham NG8 6PZ, UK; School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Byrom Street, Liverpool L3 3AF, UK.
Magdalena Zernicka-GoetzMammalian Embryo and Stem Cell Group, Department of Physiology, Development, and Neuroscience, University of Cambridge, Downing Street, Cambridge CB2 3EG, UK; Plasticity and Self-Organization Group, Division of Biology and Biological Engineering, California Institute of Technology (Caltech), Pasadena, CA 91125, USA. Electronic address: mz205@cam.ac.uk.
University of Cambridge · GBLiverpool John Moores University · GBMax Planck Institute of Biochemistry · DE

Funding

Placental models to support embryogenesis in vitroDP1HD104575 · NICHD · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI ZERNICKA-GOETZ, MAGDALENA · 2020 to 2024
$5.8M
Temporal program for cell fate specification in the mouse embryoR01HD100456 · NICHD · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI Magdalena Zernicka-Goetz · 2020 to 2026
$3.3M
NICHD NIH HHS DP1 HD104575NICHD NIH HHS R01 HD100456Wellcome TrustWellcome Trust 207415/Z/17/Z
6 · The paper itself

Abstract

At implantation, the embryo establishes contacts with the maternal endometrium. This stage is associated with a high incidence of preclinical pregnancy losses. While the maternal factors underlying uterine receptivity have been investigated, the signals required by the embryo for successful peri-implantation development remain elusive. To explore these, we studied integrin β1 signaling, as embryos deficient for this receptor degenerate at implantation. We demonstrate that the coordinated action of pro-survival signals and localized actomyosin suppression via integrin β1 permits the development of the embryo beyond implantation. Failure of either process leads to developmental arrest and apoptosis. Pharmacological stimulation through fibroblast growth factor 2 (FGF2) and insulin-like growth factor 1 (IGF1), coupled with ROCK-mediated actomyosin inhibition, rescues the deficiency of integrin β1, promoting progression to post-implantation stages. Mutual exclusion between integrin β1 and actomyosin seems to be conserved in the human embryo, suggesting the possibility that these mechanisms could also underlie the transition of the human epiblast from pre- to post-implantation.

Indexed as

MorphogenesisActomyosinAmidesAnimalsEmbryo ImplantationEmbryo, MammalianEmbryonic DevelopmentFemaleFibroblast Growth Factor 2Germ LayersGlycogen Synthase Kinase 3HumansInsulin-Like Growth Factor IIntegrin beta1MiceMice, Inbred C57BLActomyosinAmidesFibroblast Growth Factor 2Glycogen Synthase Kinase 3Insulin-Like Growth Factor IIntegrin beta1Pyridinesrho-Associated KinasesY 27632actomyosinapoptosisepiblasthuman embryointegrinsmorphogenesismouse embryosurvival

Identifiers

PMID33691117
PMCPMC7966855
OpenAlexW3135788257

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.